Ziprasidone versus risperidone in schizophrenia: An eight-week, double-blind trial with forty four-week continuation

被引：3
|
作者：
Benattia, I [1 ]
Addington, D [1 ]
Pantelis, C [1 ]
Dineen, M [1 ]
Murray, S [1 ]
机构：
[1] Pfizer Inc, New York, NY USA
来源：
SCHIZOPHRENIA RESEARCH | 2003年 / 60卷 / 01期
关键词：
D O I：
10.1016/S0920-9964(03)80431-0
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：273 / 273
页数：1
相关论文
共 50 条
  • [21] Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia:: results of a 12-week, double-blind study
    Olié, JP
    Spina, E
    Murray, S
    Yang, RY
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2006, 21 (03) : 143 - 151
  • [22] Predictors of long-term outcome in schizophrenia: A double-blind, 196-week study of ziprasidone and haloperidol
    Loebel, A.
    Potkin, S.
    Harvey, P.
    Warrington, L.
    Siu, C.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 442 - 442
  • [23] Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR
    Hewett, K.
    Chrzanowski, W.
    Schmitz, M.
    Savela, A.
    Milanova, V.
    Gee, M.
    Krishen, A.
    Millen, L.
    Leary, M. O.
    Modell, J.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2009, 23 (05) : 531 - 538
  • [24] Melatonin attenuates antipsychotic metabolic effects: an eight-week randomized, double-blind, parallel-group, placebo-controlled clinical trial
    Romo-Nava, Francisco
    Alvarez-Icaza Gonzalez, Deni
    Fresan-Orellana, Ana
    Saracco Alvarez, Ricardo
    Becerra-Palars, Claudia
    Moreno, Julia
    Ontiveros Uribe, Martha P.
    Berlanga, Carlos
    Heinze, Gerhard
    Buijs, Ruud M.
    BIPOLAR DISORDERS, 2014, 16 (04) : 410 - 421
  • [25] Double-blind comparison of ziprasidone and risperidone in the treatment of Chinese patients with acute exacerbation of schizophrenia
    Zhang, Hongyan
    Li, Huafang
    Shu, Liang
    Gu, Niufan
    Wang, Gang
    Weng, Yongzhen
    Xie, Shiping
    Zhang, Xinbao
    Li, Ting
    Ma, Cui
    Yu, Wei
    Parsons, Bruce
    Schou, Manjula
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2011, 7 : 77 - 85
  • [26] Randomized, double-blind, placebo, and risperidone-controlled study of lurasidone in the treatment of schizophrenia: Results of an inconclusive 6-week trial
    Higuchi, Teruhiko
    Iyo, Masaomi
    Kwon, Jun Soo
    Chou, Yuan-Hwa
    Chen, Hsing-Kang
    Chen, Jen-Yeu
    Chen, Tzu-Ting
    Huang, San-Yuan
    Lee, Jung-Sik
    Saeki, Yuichi
    Tanaka, Hisashi
    Wang, Tzong-Shi
    Wu, Bo-Jian
    Katoh, Takao
    Ishigouoka, Jun
    ASIA-PACIFIC PSYCHIATRY, 2019, 11 (03)
  • [27] A 6 Week Randomized Double-Blind Placebo-Controlled Trial of Ziprasidone for the Acute Depressive Mixed State
    Patkar, Ashwin
    Gilmer, William
    Pae, Chi-un
    Voehringer, Paul A.
    Ziffra, Michael
    Pirok, Edward
    Mulligan, Molly
    Filkowski, Megan M.
    Whitham, Elizabeth A.
    Holtzman, Niki S.
    Thommi, Sairah B.
    Logvinenko, Tanya
    Loebel, Antony
    Masand, Prakash
    Ghaemi, S. Nassir
    PLOS ONE, 2012, 7 (04):
  • [28] Negative symptoms and quality of life: A randomized, 196-week, double-blind study of ziprasidone versus haloperidol
    Stahl, S.
    Loebel, A.
    Malla, A.
    Newcomer, J.
    Watsky, E.
    Harvey, P.
    Weiden, P.
    Siu, C.
    Romano, S.
    EUROPEAN PSYCHIATRY, 2008, 23 : S148 - S148
  • [29] A Post Hoc Analysis of Negative Symptoms and Psychosocial Function in Patients With Schizophrenia A 40-Week Randomized, Double-Blind Study of Ziprasidone Versus Haloperidol Followed by a 3-Year Double-Blind Extension Trial
    Stahl, Stephen M.
    Malla, Ashok
    Newcomer, John W.
    Potkin, Steven G.
    Weiden, Peter J.
    Harvey, Philip D.
    Loebel, Antony
    Watsky, Eric
    Siu, Cynthia O.
    Romano, Steve
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 30 (04) : 425 - 430
  • [30] Ziprasidone Vs Olanzapine in Recent-Onset Schizophrenia and Schizoaffective Disorder: Results of an 8-Week Double-Blind Randomized Controlled Trial
    Grootens, K. P.
    van Veelen, N. M. J.
    Peuskens, J.
    Sabbe, B. G. C.
    Thys, E.
    Buitelaar, J. K.
    Verkes, R. J.
    Kahn, R. S.
    SCHIZOPHRENIA BULLETIN, 2011, 37 (02) : 352 - 361
12345